contract-pharma-logo

This article was written by Jonathan Andrus, Chief Business Officer at Clinical Ink to appear in the August 2019 Expert Opinion issue of Contract Pharma.

In this article you’ll learn:

  • How EDC methods and technologies empower more successful RBM strategies
  • What to consider when planning and conducting RBM for trials  
  • What tools and technologies are available that can help organizations embrace a comprehensive risk-based approach